Article

SteatoSITE: an Integrated Gene-to-Outcome Data Commons for Precision Medicine Research in NAFLD

2023-04-18

Abstract excerpt

<title>Abstract</title> <p>Nonalcoholic fatty liver disease (NAFLD) is the commonest cause of chronic liver disease worldwide and a growing healthcare burden. The pathobiology of NAFLD is complex, disease progression is variable and unpredictable, and there are no qualified prognostic biomarkers or licensed pharmacotherapies that can improve clinical outcomes; it represents an unmet precision medicine challenge....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d3e486ed-2b0b-5cf1-b4bf-f601707778b7
DOI: 10.21203/rs.3.rs-2805134/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SteatoSITE: an Integrated Gene-to-Outcome Data Commons for Precision Medicine Research in NAFLDDOI 10.21203/rs.3.rs-2805134/v1Read

Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLDSemantic proximity Read

Integrative multi-omics and multi-trait analysis prioritizes regulatory mechanisms and genes for metabolic dysfunction-associated steatotic liver diseaseSemantic proximity Read

Integration of transcriptomic analysis and multiple machine learning approaches identifies NAFLD progression-specific hub genes to reveal distinct genomic patterns and actionable targetsSemantic proximity Read

A proteo-transcriptomic map of non-alcoholic fatty liver disease signaturesSemantic proximity Read

Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read

Unveiling the pathogenesis of non-alcoholic fatty liver disease by decoding biomarkers through integrated single-cell and single-nucleus profilesSemantic proximity Read

Cracking the code: lncRNA-miRNA-mRNA integrated network analysis unveiling lncRNAs as promising non-invasive NAFLD biomarkers toward precision diagnosisSemantic proximity Read

A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severitySemantic proximity Read

MegaMASLD: An interactive platform for exploring stratified transcriptomic signatures in MASLD progressionSemantic proximity Read

Decoding MASLD Progression: A Molecular Trajectory-Based Framework for Modelling Disease DynamicsSemantic proximity Read

Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progressionSemantic proximity Read

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severitySemantic proximity Read